Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RABIES VACCINE INDUSTRY
2.1 Summary about Rabies Vaccine Industry
2.2 Rabies Vaccine Market Trends
2.2.1 Rabies Vaccine Production & Consumption Trends
2.2.2 Rabies Vaccine Demand Structure Trends
2.3 Rabies Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Vero cell rabies vaccine
4.2.2 BHK
4.2.3 Chick embryo cell rabies vaccine
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pre-exposure Prophylaxis
4.3.2 Post-exposure Prophylaxis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Vero cell rabies vaccine
5.2.2 BHK
5.2.3 Chick embryo cell rabies vaccine
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pre-exposure Prophylaxis
5.3.2 Post-exposure Prophylaxis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Vero cell rabies vaccine
6.2.2 BHK
6.2.3 Chick embryo cell rabies vaccine
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pre-exposure Prophylaxis
6.3.2 Post-exposure Prophylaxis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Vero cell rabies vaccine
7.2.2 BHK
7.2.3 Chick embryo cell rabies vaccine
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pre-exposure Prophylaxis
7.3.2 Post-exposure Prophylaxis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Vero cell rabies vaccine
8.2.2 BHK
8.2.3 Chick embryo cell rabies vaccine
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pre-exposure Prophylaxis
8.3.2 Post-exposure Prophylaxis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Vero cell rabies vaccine
9.2.2 BHK
9.2.3 Chick embryo cell rabies vaccine
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pre-exposure Prophylaxis
9.3.2 Post-exposure Prophylaxis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi-Pasteur
10.1.2 GSK (Novartis)
10.1.3 Chengda
10.1.4 Yisheng
10.1.5 Prcmise
10.1.6 VACN
10.1.7 Changsheng
10.1.8 BCHT
10.1.9 Hissen
10.2 Rabies Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi-Pasteur
10.2.2 GSK (Novartis)
10.2.3 Chengda
10.2.4 Yisheng
10.2.5 Prcmise
10.2.6 VACN
10.2.7 Changsheng
10.2.8 BCHT
10.2.9 Hissen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
